companydata.dkNBCD A/S: Financial statements 2014
CVR: 30582462
NBCD A/S (CVR 30582462) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 1,579,482 and a net result of DKK 29,158,907 compared with DKK -11,792,867 the year before. Equity amounted to DKK 6,295,175. The solvency ratio was 8.3%.
- Gross Profit
- 1,579,482 kr.
- Profit/Loss
- 29,158,907 kr.
- Equity
- 6,295,175 kr.
- Total Assets
- 75,637,780 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 1.6 mio. | 29.2 mio. | 6.3 mio. | - |
| 2013 | - | -3.4 mio. | -11.8 mio. | -22.9 mio. | - |
| 2012 | - | - | - | 500 t. | - |
Keep an eye on NBCD A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
NBCD A/S has published its annual report for 2013. Gross profit came to DKK -3,384,452, and the net result was DKK -11,792,867.
As of January 1, 2014, Jeppe Ragnar Andersen is registered as adm. dir. of NBCD A/S.
As of January 1, 2014, Bente Juel Christiansen has stepped down as director of NBCD A/S.
About NBCD A/S
NBCD A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2007. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named NORDIC BIOSCIENCE CLINICAL DEVELOPMENT A/S and NORDIC BIOSCIENCE PROJECT 2 A/S. The management consists of Jeppe Ragnar Andersen and Mark Høgh Gandrup. The company is owned by Sanos Holding A/S. The company has 24 employees. In 2025, the company reported a gross profit of DKK 31,583,144 and a net result of DKK 9,222,892 compared with DKK 52,621,101 the year before. Equity amounted to DKK 136,144,994.